State Street Corp Axonics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Axonics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,184,492 shares of AXNX stock, worth $84.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,184,492

Previous 1,210,952 2.19%

Holding current value

$84.1 Million

Previous $81.4 Million 1.36%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.3 - $69.67 $1.78 Million - $1.84 Million	-26,460 Reduced 2.19%	1,184,492 $82.5 Million
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $1.13 Million - $1.19 Million	17,015 Added 1.43%	1,210,952 $81.4 Million
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $562,223 - $688,120	-9,921 Reduced 0.82%	1,193,937 $82.3 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $2.33 Million - $3.01 Million	47,286 Added 4.09%	1,203,858 $74.9 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $2.41 Million - $3.09 Million	-49,495 Reduced 4.1%	1,156,572 $64.9 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $3.92 Million - $4.92 Million	81,712 Added 7.27%	1,206,067 $60.9 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $3.03 Million - $3.88 Million	57,556 Added 5.4%	1,124,355 $61.3 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $3.1 Million - $3.99 Million	52,124 Added 5.14%	1,066,799 $66.7 Million
Q3 2022 Nov 15, 2022	BUY	$57.96 - $78.12 $642,544 - $866,038	11,086 Added 1.1%	1,014,675 $71.5 Million
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $306,085 - $499,190	-7,749 Reduced 0.77%	1,003,589 $56.9 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $55,549 - $79,705	1,270 Added 0.13%	1,011,338 $63.3 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $3.93 Million - $5.77 Million	78,605 Added 8.44%	1,010,068 $56.6 Million
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $2.41 Million - $3.21 Million	40,768 Added 4.58%	931,463 $60.6 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $8.46 Million - $11 Million	164,597 Added 22.67%	890,695 $56.5 Million
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $3.23 Million - $3.94 Million	-65,779 Reduced 8.31%	726,098 $43.5 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $423,334 - $516,751	10,034 Added 1.28%	791,877 $39.5 Million
Q3 2020 Nov 10, 2020	BUY	$35.33 - $51.04 $1.35 Million - $1.95 Million	38,219 Added 5.14%	781,843 $39.9 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $8.95 Million - $15.6 Million	390,557 Added 110.62%	743,624 $26.1 Million
Q1 2020 May 11, 2020	BUY	$16.44 - $37.73 $5.8 Million - $13.3 Million	353,067 New	353,067 $8.97 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Axonics, Inc. Transaction History